Chronic hepatitis B infectionin Canada

Canadian Journal of Infectious Diseases

Volumn 12, Issue 6, 2001, Pages 351-356

  Minuk, G Y ^a   Uhanova, J ^a  

^a John Buhler Research Centre   (Canada)

Author keywords

Canada; Epidemiology; Hepatitis; Hepatitis B; Hepatitis B virus; Liver; Liver disease

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B VACCINE;

ABORIGINE; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CANADA; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HOMELESSNESS; HUMAN; IMMIGRANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; POPULATION RESEARCH; PREVALENCE; SERODIAGNOSIS; VACCINATION; VIRUS REPLICATION;

EID: 0035718977     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/650313     Document Type: Article

References (50)

1. Hepatitis B: Global importance and need for control
2. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: A prospective study
3. Long-term follow-up of HBeAg-positive patients treated with interferon alpha for chronic hepatitis B
4. A one-year trial of lamivudine for chronic hepatitis B
5. Hepatitis B: Evolving epidemiology and implications for control
6. A population-based hepatitis B seroprevalence and risk factor study in a northern Ontario town
7. Prevalence of hepatitis B surface antigen, hepatitis B antibody, and HIV-1 antibody among residents of a long-term care facility
8. Prevalence of HBsAg and HBsAg sub-types in the Canadian blood-donor population
9. Incidence of hepatitis B antigen and antibody among Canadian volunteer blood donors
10. Donnees statistiques concemant l'antigene australie pour la region ouest du quebec
11. Hepatitis B prenatal screening survey, Nova Scotia 1990-1991
12. Prevalence of bloodborne infective agents among people admitted to a Canadian hospital
13. Hepatitis and hepatitis B surface antigen and antibody in dentists
14. Hepatitis B antigen in Montreal blood donors: Childhood institutionalization as an epidemiologic factor
15. Differences in the distribution of e antigen among different ethnic groups in a population of blood donors
16. The hepatitis B carrier state - A follow-up study of 100 consecutive cases
17. Hepatitis-associated markers in the American Red Cross volunteer blood donor population. IV. A comparison of HBV-associated serologic markers in HBsAg-positive first-time and repeat blood donors
18. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal
19. The prevalence of antibody to delta virus in western Canada
20. Antibody to hepatitis D virus (delta agent) in selected Manitoba residents, 1974-1986
21. Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state
22. Hepatitis B-related sequelae: Prospective study in 1400 hepatitis B surface antigen-positive Alaska carriers
23. Hepatitis B virus. The major etiology of hepatocellular carcinoma
24. The changing epidemiology of hepatitis B virus infection in the Canadian North
25. Surgical management of hepatocellular carcinoma: Resection or transplantation?
26. Chronic type B hepatitis
27. Hepatitis B vaccination and screening for markers at a sexually transmitted disease clinic for men
28. Sero-epidemiologic study to determine the prevalence and risk of hepatitis B in Canadian heterosexual sexually transmitted disease population
29. Predictors of positivity for hepatitis B and the derivations of a selective screening rule in a Canadian sexually transmitted disease clinic
30. Hepatitis B and human immunodeficiency virus infection in street youths in Toronto, Canada
31. Hepatitis B virus infection among street youths in Montreal
32. Hepatitis B control in Toronto classrooms for the mentally retarded: A seroprevalence study
33. Hepatitis virus infection in an isolated Canadian Inuit (Eskimo) population
34. Chronic hepatitis B viral infections in the Canadian Inuit. A follow-up study
35. Extension of the epidemiology of hepatitis B in circumpolar regions through a comprehensive serologic study in the Northwest Territories of Canada
36. Epidemiologic features of hepatitis B virus infection in Northern Labrador
37. Putrescine levels in the staple foods of the Canadian Inuit and Hong Kong Chinese: A possible explanation for discrepant hepatocellular carcinoma rates in the two populations
38. HIV and hepatitis B surveillance in First Nations alcohol and drug treatment centres in British Columbia, Canada
39. Lack of evidence of hepatitis D (delta) infection in Newfoundland and Labrador
40. The prevalence of antibody to hepatitis C virus in an isolated Canadian Inuit settlement
41. Cancer of the digestive system in Circumpolar Inuit
42. Prevalence of hepatitis B markers in Indochinese refugees
43. Hepatitis B follow-up among Indochinese refugees
44. A cross-sectional seroepidemiologic survey of chronic hepatitis B virus infections in Southeast Asian immigrants residing in Canadian urban centre
45. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban population
46. Canadian consensus conference on the management of viral hepatitis
47. Therapy of viral hepatitis
48. Treatment and prevention of chronic viral hepatitis
49. Treatment of chronic viral hepatitis